Leptin-mediated regulation of ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell migration

Zhao‐Ru Dong(Qilu Hospital of Shandong University), Chuan Wang(Qilu Hospital of Shandong University)
British Journal of Cancer
February 18, 2014
10.1038/bjc.2014.70
Cited by 52

Related Papers

Abstract 7299: CS2009: A first-in-class trispecific antibody targeting PD-1, CTLA-4, and VEGFA with potential to be a next-generation backbone therapy with combined checkpoint inhibition and anti-angiogenesis
|Cancer Research|2025|4
504 CS2009, a novel first-in-class trispecific antibody targeting PD-1, CTLA-4, and VEGFa, demonstrates promising anti-tumor activity in preclinical evaluation
|Regular and Young Investigator Award Abstracts|2024|0
Abstract 2954: CS5007: A novel EGFR and HER3 dual-targeted antibody-drug conjugate (ADC) with potent antitumor activity in preclinical studies
|Cancer Research|2025|0
Abstract 4751: CS5005: A novel SSTR2-targeted antibody-drug conjugate (ADC) with robust antitumor activity in preclinical studies
|Cancer Research|2025|0
Abstract 2953: CS5006: A novel integrin β4-targeted antibody-drug conjugate (ADC) with robust antitumor activity in preclinical studies
|Cancer Research|2025|0